Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
With the correct selection of drug and patient, the calcium antagonists as a group can be remarkably effective at relatively low cost of serious side effects. Almost all side effects are dose related. Minor side effects include those caused by vasodilation (flushing and headaches), constipation (verapamil), and ankle edema. Serious side effects are rare and result from improper use of these agents, as when intravenous verapamil (or diltiazem) is given to patients with sinus or atrioventricular nodal depression from drugs or disease, or nifedipine to patients with aortic stenosis. The potential of a marked negative inotropic effect is usually offset by afterload reduction, especially in the case of nifedipine which actually has the most marked negative inotropic effect. Yet caution is required when even calcium antagonists, especially verapamil, are given to patients with myocardial failure unless caused by hypertensive heart disease. Drug interactions of calcium antagonists occur with other cardiovascular agents such as alpha-adrenergic blockers, beta-adrenergic blockers, digoxin, quinidine, and disopyramide. The most marked interaction with digoxin is that with verapamil, which may raise digoxin levels by over 50%. Combination therapy of calcium antagonists with beta-blockers is increasingly common, and is probably safest in the case of dihydropyridines. Other combinations being explored are those with angiotensin-converting enzyme inhibitors and diuretics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, some pharmacological side effects may be more effectively managed with exercise interventions rather than adding further medications to the patient’s regimen, potentially initiating a harmful “prescription cascade” [[544], [545], [546], [547]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [544]
Citations
Cites
Diltiazem: A Review of its Pharmacological Properties and Therapeutic Efficacy
Chaffman, M., & Brogden, R. N. (1985) · Drugs · doi:10.2165/00003495-198529050-00001 · Cited by 373 · cited 1×
“Besides additive effects on nodal tissue and additive negative inotropic effects, diltiazem can displace propranolol from plasma binding sites thereby elevating free propranolol levels [ 69 ].”
BackgroundSorkin, E. M., Clissold, S. P., & Brogden, R. N. (1985) · Drugs · doi:10.2165/00003495-198530030-00002 · Cited by 355 · cited 1×
“Nifedipine data from [3], [15], [16], [99], and [100]. See also [ 101 ].”
BackgroundTorsade De Pointes, an atypical ventricular tachycardia.
Krikler, D. M., & Curry, P. V. (1976) · Heart · doi:10.1136/hrt.38.2.117 · Cited by 344 · cited 1×
“Such side effects have not been reported with the three prototypical calcium antagonists but only with prenylamine, lidoflazine, and bepridil which may all prolong the Q-T interval with potential for precipitation of atypical ventricular tachycardia [45].”
BackgroundHemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.
Packer, M., Meller, J., Medina, N., Yushak, M., Smith, H., Holt, J., Guererro, J., Todd, G. D., McAllister, R. G., & Gorlin, R. (1982) · Circulation · doi:10.1161/01.cir.65.4.660 · Cited by 332 · cited 1×
“verapamil [56] can reduce contractility [56], increase”
Calcium Antagonists and Cardiovascular Disease
McGoon, M. D. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60308-5 · Cited by 232
Nifedipine in hypertensive emergencies.
Bertel, O., Conen, D., Radü, E. W., Müller, J., Lang, C., & Dubach, U. C. (1983) · BMJ · doi:10.1136/bmj.286.6358.19 · Cited by 222
Roth, A., Harrison, E., Mitani, G., Cohen, J., Rahimtoola, S. H., & Elkayam, U. (1986) · Circulation · doi:10.1161/01.cir.73.2.316 · Cited by 196 · cited 2×
“Diltiazem 360 mg daily given instead of digoxin caused side effects in 9 of 12 patients (75%) with atrial fibrillation; 11 of these patients had mitral valve disease [38].”
BackgroundLynch, P., Dargie, H., Krikler, S., & Krikler, D. (1980) · BMJ · doi:10.1136/bmj.281.6234.184 · Cited by 191
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.
Kimura, E., & Kishida, H. (1981) · Circulation · doi:10.1161/01.cir.63.4.844 · Cited by 190 · cited 1×
“In a small open series [74], nifedipine plus diltiazem appears to be effective in all”
BackgroundDifferential cardiovascular effects of calcium channel blocking agents: Potential mechanisms
Millard, R. W., Lathrop, D. A., Grupp, G., Ashraf, M., Grupp, I. L., & Schwartz, A. (1982) · The American Journal of Cardiology · doi:10.1016/s0002-9149(82)80002-7 · Cited by 187 · cited 1×
“dipine may be considerably more powerful than verapamil or diltiazem in decreasing vagal tone [61],”
BackgroundHung, J., Lamb, I. H., Connolly, S. J., Jutzy, K. R., Goris, M. L., & Schroeder, J. S. (1983) · Circulation · doi:10.1161/01.cir.68.3.560 · Cited by 158 · cited 4×
“[41] and a lesser risk of a negative inotropic effect than with verapamil (see Table I-6).”
BackgroundInfluentialAdverse interaction between nifedipine and beta-blockade.
Opie, L. H., & White, D. A. C. (1980) · BMJ · doi:10.1136/bmj.281.6253.1462 · Cited by 135 · cited 3×
“Nifedipine has caused excess hypotension or cardiovascular depression only in a few seriously ill patients [9, 10].”
BackgroundSelf-citationBassan, M. M., Weiler-Ravell, D., & Shalev, O. (1983) · Circulation · doi:10.1161/01.cir.68.3.568 · Cited by 132 · cited 1×
“Because calcium channel antagonists are equally effective with isosorbide dinitrate in the therapy of patients with angina already receiving propranolol [88], and because of the problems with nitrate tolerance recently raised, the combination of calcium channel antagonist-~-blocker is being increasingly used.”
BackgroundProduction of ischaemic cardiac pain by nifedipine.
Jariwalla, A. G., & Anderson, E. G. (1978) · BMJ · doi:10.1136/bmj.1.6121.1181 · Cited by 131 · cited 1×
“Myocardial ischemia can be precipitated [20, 21] so that in the therapy of angina pectoris, dose titration of nifedipine is required.”
BackgroundEfficacy of diltiazem in angina on effort: A multicenter trial
Hossack, K. F., Pool, P. E., Steele, P., Crawford, M. H., DeMaria, A. N., Cohen, L. S., Ports, T. A., & Skalland, L. (1982) · The American Journal of Cardiology · doi:10.1016/s0002-9149(82)80013-1 · Cited by 129 · cited 1×
“In the United States, the package insert claims that side effects of oral therapy are similar to those of placebo, but lists nausea (3%), pedal edema (2%), headache (2%), and heart block (0.4%), and in two trials diltiazem for stable angina was "remarkably free of adverse effects" in doses of 240 mg daily [ 33 ] and a…”
BackgroundInfluentialVERAPAMIL POTENTIATES CARBAMAZEPINE NEUROTOXICITY: A CLINICALLY IMPORTANT INHIBITORY INTERACTION
Macphee, G. J., McInnes, G. T., Thompson, G. G., & Brodie, M. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91099-8 · Cited by 126 · cited 1×
“Verapamil 360 mg daily added to carbamazepine, an agent used in the therapy of epilepsy, caused blood concentrations of the latter to rise with side effects of excess carbamazepine 186 Opie (diplopia, headache, dizziness)[ 87 ].”
BackgroundGuazzi, M. D., Cesare, N. D., Galli, C. L., Salvioni, A., Tramontana, C., Tamborini, G., & Bartorelli, A. (1984) · Circulation · doi:10.1161/01.cir.70.2.279 · Cited by 123
Unpredictable response to nifedipine in severe cardiac failure.
Brooks, N. H., Cattell, M., Pidgeon, J., & Balcon, R. (1980) · BMJ · doi:10.1136/bmj.281.6251.1324 · Cited by 121
Opie, L. H. (1980) · PubMed · Cited by 118
Self-citationPulmonary oedema precipitated by nifedipine.
Gillmer, D. J., & Kark, P. (1980) · BMJ · doi:10.1136/bmj.280.6229.1420 · Cited by 108 · cited 1×
“One patient with aortic stenosis [26] given nifedipine for acute pulmonary edema developed severe heart failure.”
BackgroundAdverse Reactions to Calcium Antagonists
Lewis, J. (1983) · Drugs · doi:10.2165/00003495-198325020-00006 · Cited by 103
Petru, M. A., Crawford, M. H., Sorensen, S. G., Chaudhuri, T. K., Levine, S. P., & O’Rourke, R. A. (1983) · Circulation · doi:10.1161/01.cir.68.1.139 · Cited by 102 · cited 2×
“See also [17], [36], [38], [39], and [102].”
BackgroundMicrovascular Mechanisms Involved in Calcium Antagonist Edema Formation
Gustafsson, D. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710001-00023 · Cited by 97 · cited 3×
“Ankle edema is more likely to occur in patients with varicose veins or lower leg paresis [1].”
BackgroundInfluentialAdverse reactions with calcium antagonists.
Krebs, R. (1983) · Hypertension · doi:10.1161/01.hyp.5.4_pt_2.ii125 · Cited by 95 · cited 3×
“When glucose tolerance does deteriorate, it may be the result of reflex sympathetic stimulation [28].”
BackgroundDiabetogenic effects of nifedipine.
Bhatnagar, S. K., Amin, M., & Al-Yusuf, A. R. (1984) · BMJ · doi:10.1136/bmj.289.6436.19 · Cited by 94
Johnston, D. L., Lesoway, R., Humen, D. P., & Kostuk, W. J. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90136-5 · Cited by 88 · cited 8×
“Also in patients with angina pectoris already receiving propranolol or metoprolol, intravenous [55] or oral verapamil [56] can reduce contractility [56], increase heart size [57], and cause symptomatic sinus bradycardia [58], Depending on the dose, the combination may be well tolerated [ 57 ] or not tolerated [41].”
BackgroundMethodInfluentialRole of nifedipine in treatment of hypertension.
Murphy, M. B., Scriven, A., & Dollery, C. T. (1983) · BMJ · doi:10.1136/bmj.287.6387.257 · Cited by 87 · cited 1×
“Hypokalemia, although found in one study when nifedipine was combined with a diuretic and ~]blocker [30], could not be found in another study when a similar combination was made [31].”
ResultPool, P. E., Massie, B. M., Venkataraman, K., Hirsch, A. T., Samant, D. R., Seagren, S. C., Gaw, J., Salel, A. F., Tubau, J. F., Vollmer, C., et al. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90893-3 · Cited by 83 · cited 1×
“sion(usually 360 mg daily) caused a somewhat similar incidence of dizziness, edema, and headaches [37].”
BackgroundTilmant, P. Y., Lablanche, J. M., Thieuleux, F. A., Dupuis, B., & Bertrand, M. E. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90113-3 · Cited by 81
Nifedipine-induced renal dysfunction
Diamond, J. R., Cheung, J. Y., & Fang, L. S. T. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90540-0 · Cited by 81
Culling, W., Ruttley, M. S. T., & Sheridan, D. J. (1984) · Heart · doi:10.1136/hrt.52.4.431 · Cited by 80 · cited 1×
“When felodipine plus atenolol was given to patients with coronary artery disease and no heart failure, the systemic vascular resistance fell, the cardiac index rose, but there was no negatively inotropic effect manifest by first derivative of left ventricular pressure (dP/dt) [ 72 ].”
BackgroundNifedipine therapy in angina pectoris: Evaluation of safety and side effects
Terry, R. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90256-3 · Cited by 71 · cited 2×
“In the majority of patients without serious pre-existing myocardial disease, nifedipine has been given with only a few side effects (see Table IV-2) such as facial flushing, headaches, heat sensations, ankle edema, and exaggeration of varicose veins [15, 16].”
BackgroundKieval, J., Kirsten, E. B., Kessler, K. M., Mallon, S. M., & Myerburg, R. J. (1982) · Circulation · doi:10.1161/01.cir.65.4.653 · Cited by 70 · cited 1×
“propranolol or metoprolol, intravenous [55] or oral”
Steinberg, J. S., Katz, R. J., Bren, G. B., Buff, L. A., & Varghese, P. J. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80396-0 · Cited by 66 · cited 2×
“See also [17], [36], [38], [39], and [102].”
BackgroundPrida, X. E., Gelman, J. S., Feldman, R. L., Hill, J. A., Pepine, C. J., & Scott, E. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80397-2 · Cited by 65 · cited 4×
“However, a recent open-label study [17] suggests that the combination of both in high doses (diltiazem 360”
BackgroundInfluential“Maximal” drug therapy is not necessarily optimal in chronic angina pectoris
Tolins, M., Weir, Ε. K., Chesler, E., & Pierpont, G. L. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80366-6 · Cited by 64 · cited 2×
“One study says "no," probably because of the problem of hypotension [89].”
BackgroundPepine, C. J., Feldman, R. L., Hill, J. A., Conti, C. R., Mehta, J. L., Hill, C. K., & Scott, E. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90043-1 · Cited by 61 · cited 1×
“The incidence of constipation occurs in 25% to 40% of patients [2, 3]. With a higher mean dose (416 mg daily), constipation occurred in 10 of 16 patients, i.e., 63% [ 4 ].”
BackgroundEfficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris
Lindenberg, B. S., Weiner, D. A., McCabe, C. H., Cutler, S. S., Ryan, T. J., & KLEIN, M. D. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80339-8 · Cited by 61 · cited 1×
“4%), and in two trials diltiazem for stable angina was "remarkably free of adverse effects" in doses of 240 mg daily [33] and all doses (up to 360 mg daily) were "extremely well tolerated" [34].”
BackgroundFerlinz, J., & Citron, P. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90309-0 · Cited by 61 · cited 1×
“Heart failure remains a contraindication to verapamil, even though this drug has been successfully given with care to such patients [ 47 ].”
BackgroundFrishman, W. H., Zawada, E. T., Smith, L. K., Sowers, J. R., Swartz, S. L., Kirkendall, W. M., Lunn, J., McCarron, D. A., Moser, M., & Schnaper, H. W. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91180-5 · Cited by 60 · cited 2×
“Diltiazem data from [35], [ 102 ], and [103].”
MethodMaisel, A. S., Motulsky, H. J., & Insel, P. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120308 · Cited by 56
Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.
Dawson, J. R., Whitaker, N. H., & Sutton, G. C. (1981) · Heart · doi:10.1136/hrt.46.5.508 · Cited by 56 · cited 1×
“The minor side effects of verapamil, apart from constipation, are somewhat less than those of nifedipine when both are used in doses equipotent for chronic stable angina [ 5 ] or hypertension [6].”
BackgroundSmith, S., Kendall, M. J., Lobo, J., Beerahee, A., Jack, D. B., & Wilkins, M. R. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03050.x · Cited by 55
Oyama, Y., Fujii, S., Kanda, K., Akino, E., 川崎, 久., Nagata, M., & Katsuhiro, G. O. T. O. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)91653-9 · Cited by 55 · cited 1×
“An advantage of nifedipine and diltiazem is that such major interactions with digoxin have not yet been established [78, 79], although relatively small increases have also been reported [ 80 , 81].”
ResultDrug Interactions with Nitrendipine
Kirch, W., Hutt, H., Heidemann, H. T., msch, K. R., Janisch, H. D., & Ohnhaus, E. E. (1984) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198400067-00011 · Cited by 52 · cited 1×
“20% [82] and in the case of nisoldipine, greater increases up to doubling have been reported [83].”
BackgroundVerapamil in cardiac arrhythmias.
Sacks, H. S., & Kennelly, B. M. (1972) · BMJ · doi:10.1136/bmj.2.5815.716-a · Cited by 51
Opie, L. H., JEE, L. D., & White, D. A. C. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90234-4 · Cited by 50 · cited 1×
“plementary qualities of these agents [19, 63, 64]; and 2) the relatively few contraindications to nifedipine.”
BackgroundSelf-citationVerapamil compared with nifedipine in the treatment of essential hypertension.
Midtbø, K., Hals, O., & van der Meer, J. (1982) · PubMed · Cited by 48
Pfisterer, M. E., Müller‐Brand, J., & Burkart, F. E. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90053-4 · Cited by 48 · cited 1×
“Nifedipine. Potentially the indirect positive inotropic effect of nifedipine, acting via afterload reduction, is capable of offsetting the negative effects of 6adrenoceptor blockade [57, 60 ].”
BackgroundThe effect of nifedipine on serum digoxin concentrations in patients
Schwartz, J. B., Raizner, A. E., & Akers, S. Z. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90313-2 · Cited by 47 · cited 1×
“such major interactions with digoxin have not yet been established [78, 79], although relatively small in-”
BackgroundStone, P. H. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90089-0 · Cited by 46 · cited 1×
“Nifedipine data from [3], [15], [16], [ 99 ], and [100].”
Drug interactions with the calcium-entry blockers.
Piepho, R. W., Culbertson, V. L., & Rhodes, R. S. (1987) · PubMed · Cited by 46
Elkayam, U., Parikh, K. H., Torkan, B., Weber, L., Cohen, J. L., & Rahimtoola, S. H. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90511-9 · Cited by 45 · cited 1×
“such major interactions with digoxin have not yet been established [78, 79], although relatively small in-”
BackgroundAPetru, M., HCrawford, M., GSorensen, S., et al. (1983) · Circulation · Cited by 45
Experimental studies on the pathogenesis of asystole after verapamil in the dog
Urthaler, F., & James, T. N. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90283-2 · Cited by 44 · cited 1×
“presence of pre-existing ~-adrenergic blockade [54].”
Acute hypotensive response to nifedipine added to prazosin in treatment of hypertension.
JEE, L. D., & Opie, L. H. (1983) · BMJ · doi:10.1136/bmj.287.6404.1514 · Cited by 44 · cited 2×
“nifedipine or prazosin should both be added cautiously and in low dose to the therapy of patients already receiving the other agent [49].”
BackgroundMethodSelf-citationCaptopril and nifedipine in combination for moderate to severe essential hypertension.
Singer, D. R. J., Markandu, N. D., Shore, A. C., & MacGregor, G. A. (1987) · Hypertension · doi:10.1161/01.hyp.9.6.629 · Cited by 44 · cited 1×
“In another unblinded study, not placebo-controlled, nifedipine tablets 20 mg twice daily and captopri125 mg three times daily had an additive hypotensive effect, wearing off 12 hours after the tablets were given [91].”
Hepatotoxicity Due to Treatment With Verapamil
Brodsky, S. J., Cutler, S. S., Weiner, D. A., & KLEIN, M. D. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-490 · Cited by 42 · cited 1×
“Rare side effects include hepatotoxicity [14], oc-”
Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects
Pasanisi, F., Elliott, H. L., Meredith, P., McSharry, D. R., & Reid, J. L. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.247 · Cited by 39
Warltier, D. C., Zyvoloski, M. G., Gross, G. J., & Brooks, H. L. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21492-6 · Cited by 38 · cited 1×
“although the experimental data are in conflict [62].”
BackgroundEinfluß von Cimetidin und Ranitidin auf Pharmakokinetik und antihypertensiven Effekt von Nifedipin
Kirch, W., Janisch, H. D., Heidemann, H. T., Rämsch, K. D., & Ohnhaus, E. E. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1069821 · Cited by 37
Marone, C. C., Luisoli, S., Bomio, F., Beretta-Piccoli, C., Bianchetti, M. G., & Weidmann, P. U. (1985) · Kidney International · doi:10.1038/ki.1985.180 · Cited by 37 · cited 1×
“Although ankle swelling does not indicate edematous fluid retention [23], careful balanced studies have shown that nifedipine administration is accompanied by an overall sodium retention, presumably in the extravascular space [24].”
BackgroundWinniford, M. D., Fulton, K. L., Corbett, J. R., Croft, C. H., & Hillis, L. D. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90361-3 · Cited by 35 · cited 1×
“Also in patients with angina pectoris already receiving propranolol or metoprolol, intravenous [55] or oral verapamil [56] can reduce contractility [56], increase heart size [57], and cause symptomatic sinus bradycardia [ 58 ], Depending on the dose, the combination may be well tolerated [57] or not tolerated [41].”
BackgroundPedersen, K. E. (1985) · PubMed · Cited by 35
Atrioventricular Dissociation and Sinus Arrest Induced by Oral Diltiazem
Ishikawa, T., Imamura, T., Koiwaya, Y., & Tanaka, K. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311033091813 · Cited by 34
Calcium entry blockers for systemic hypertension
Moser, M. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90186-x · Cited by 32
Calcium antagonists and the second drug for hypertensive therapy
Müller, F., Bolli, P., Linder, L., Kiowski, W., Erné, P., & Bühler, F. R. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90791-6 · Cited by 32 · cited 1×
“In a third open-label study, enalapril (mean daily dose about 30 mg) was added to verapamil (slow-release, mean daily dose 460 mg) again with additive hypotensive effects [92].”
BackgroundClearance-based oral drug interaction between verapamil and metoprolol and comparison with atenolol
McLean, A. J., Knight, R., Harrison, P. M., & Harper, R. W. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90987-7 · Cited by 32 · cited 1×
“An unexpected interaction has been shown between verapamil and metoprolol, verapamil raising the blood level of metoprolol but not of atenolol, probably because of the hepatic metabolism of metoprolol, whereas atenolol is a strictly hydrophilic agent [ 59 ].”
BackgroundDaniels, A. R., & Opie, L. H. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90740-x · Cited by 31 · cited 2×
“From [94] by courtesy of American Journal of Cardiology.”
BackgroundSelf-citationDuncker, D. J., Hartog, J. M., Hugenholtz, P. G., Saxena, P. R., & Verdouw, P. D. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb09465.x · Cited by 30
Calcium antagonists in chronic stable angina pectoris
Subramanian, V. B. (1983) · Medical Entomology and Zoology · Cited by 29
Experimental Myocardial Infarction in Adjuvant Arthritic Rats
Koltai, M., Leprán, I., Nemecz, G., & Szekeres, L. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198205000-00004 · Cited by 28
Gottlieb, S. O., Ouyang, P., Achuff, S. C., Baughman, K. L., Traill, T. A., Mellits, E. D., Weisfeldt, M. L., & Gerstenblith, G. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80230-2 · Cited by 28
Ventricular arrhythmias associated with lidoflazine: side-effects observed in a randomized trial
Hanley, S. P., & Hampton, J. R. (1983) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061417 · Cited by 27
Aggravation of myocardial ischaemia by nifedipine
SIa, S., Macdonald, P. S., Triester, B., Oliver, L. E., Horowitz, J. D., & Coble, A. J. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb113286.x · Cited by 26 · cited 1×
“Myocardial ischemia can be precipitated [20, 21] so that in the therapy of angina pectoris, dose titration of nifedipine is required.”
BackgroundWhite, H. D., Polak, J. F., Wynne, J., Holman, B. L., Antman, E. M., & Nesto, R. W. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90493-x · Cited by 24 · cited 1×
“In another study, nifedipine 80 to 120 mg was added to patients already receiving both 13blockers and nitrates [ 90 ].”
BackgroundInteraction Between Digoxin and Nifedipine at Steady State in Patients with Atrial Fibrillation
Kleinbloesem, C. H., van Brummelen, P., Hillers, J. A., Moolenaar, A. J., & Breimer, D. D. (1985) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198512000-00002 · Cited by 22 · cited 1×
“An advantage of nifedipine and diltiazem is that such major interactions with digoxin have not yet been established [78, 79], although relatively small increases have also been reported [80, 81 ].”
ResultJack, D. B., Smith, R. N., & Wise, P. J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-768_2 · Cited by 22
VERAPAMIL IN THE LONG–TERM TREATMENT OF ANGINA PECTORIS
Raftos, J. R. (1980) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1980.tb76885.x · Cited by 20
Daniels, A. R., & Opie, L. H. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90386-9 · Cited by 17
Self-citationCombination therapy with diltiazem and propranolol: Precipitation of congestive heart failure
Strauss, W., McIntyre, K. M., Parisi, A. F., & Egan, T. (1985) · Clinical Cardiology · doi:10.1002/clc.4960080612 · Cited by 17 · cited 1×
“block, or even to congestive heart failure [42].”
BackgroundRosenkranz, B., Ledermann, H., & Frölich, J. C. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198609000-00010 · Cited by 17 · cited 1×
“Thus, it is simpler to combine nifedipine with atenolol which undergoes no first-pass liver metabolism and does not alter nifedipine kinetics [ 68 ].”
MethodHugenholtz, P. G., Verdouw, P. D., de Jong, J. W., & Serruys, P. W. J. C. (1983) · PubMed · doi:10.1136/pgmj.59.687.40 · Cited by 17
Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.
Sowers, J. R., & Pk, M. (1987) · PubMed · Cited by 15
Absence of rebound from diltiazem therapy in Prinzmetal's variant angina
Schroeder, J. S., Walker, S. D., Skalland, M. L., & Hemberger, J. A. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80271-0 · Cited by 14
Rocha, P., Zannier, D., Baron, B., Pathé, M., David, D., & Kahn, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91090-3 · Cited by 13 · cited 1×
“Intravenous nicardipine (5 mg) given to patients with coronary artery disease without heart failure, already receiving large doses of propranolol, decreased the systemic vascular resistance and increased cardiac output [ 71 ].”
BackgroundPreclinical and clinical pharmacokinetics of pirmenol
Chang, T. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90139-1 · Cited by 13
Acute hypotensive response to nifedipine added to prazosin
Elliott, H. L., Pasanisi, F., Meredith, P. A., & Reid, J. L. (1984) · BMJ · doi:10.1136/bmj.288.6412.238-b · Cited by 10
Muscle cramps during treatment with nifedipine.
Macdonald, J. B. (1982) · BMJ · doi:10.1136/bmj.285.6356.1744 · Cited by 10
Myers, M. G., Leenen, F. H. H., Burns, R. A., & Frankel, D. Z. N. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.63 · Cited by 10 · cited 1×
“Hypokalemia, although found in one study when nifedipine was combined with a diuretic and ~]blocker [30], could not be found in another study when a similar combination was made [31].”
ResultInteraction between dicoxine and calcium antagonist
Lessem, J. N., & Bellinetto, A. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)92508-5 · Cited by 9
The influence of alpha1-adrenergic blockade on the acute antihypertensive effect of nifedipine
Sluiter, H. E., Huysmans, F. T. M., Thien, T., & Koene, R. A. P. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544078 · Cited by 9
FLUID RETENTION WITH NIFEDIPINE IN ANTIHYPERTENSIVE THERAPY
OPIE, L. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92761-3 · Cited by 9 · cited 1×
“Although ankle swelling does not indicate edematous fluid retention [23], careful balanced studies have shown that nifedipine administration is accompanied by an overall sodium retention, presumably in the extravascular space [24].”
BackgroundSelf-citationNifedipine for angina and acute myocardial ischemia
Hugenholtz, P., de Jong, J. W., Verdouw, P., & Serruys, P. W. J. C. (1983) · RePub (Erasmus University Rotterdam) · Cited by 8
Hamann, S. R., Kaltenborn, K. E., & McAllister, R. G. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198708000-00008 · Cited by 7 · cited 1×
“nifedipine and propranolol are given together in high doses to anesthetized dogs[ 66 ].”
BackgroundCSM Update: Annual review of yellow cards--1985
(1986) · BMJ · doi:10.1136/bmj.293.6548.688 · Cited by 6 · cited 1×
“In the United Kingdom the annual report on side effects of new drugs noted in 1985 that there were some cases of serious skin reactions such as exfoliative dermatitis and epidermal necrolysis [43].”
BackgroundCombined use of digoxin and nifedipine in the treatment of congestive heart failure
Neufeld, J. (1985) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(85)80899-4 · Cited by 5
Evaluation of Combined Administration of Verapamil and Disopyramide in Dogs
Lee, J. T., Davy, J., & Kates, R. E. (1985) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198505000-00014 · Cited by 5 · cited 1×
“tense sinus node depression, leading to concern that this interaction may be harmful in patients [86].”
BackgroundVerapamil in the long-term treatment of angina pectoris.
Raftos, J. R. (1982) · PubMed · Cited by 2
Research works printed but not linked: 11
- Fleckenstein A. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Harris P, Opie LH, eds. Calcium and the Heart. London: Academic Press, 1971;135?188.
- Opie LH, Singh BN. Calcium channel antagonists (slow channel blockers). In: Opie LH, ed. Drugs for the Heart Second Expanded Edition. Orlando, Florida: Grune & Stratton, 1987;34?53
- Norris RJ, Brooks SG. Pharmacokinetics of a sustained release formulation of verapamil in young and elderly adults. In: Raftery EB, ed. Verapamil SR. Once-daily Calcium Blockade in Angina and Hypertension. Langhorne: ADIS Press International, 1987;38?46.
- Leisten L, Kuhlmann J, Ebner F. Side effects and pharmacodynamic interactions. In: Krebs R, ed. Treatment of Cardiovascular Diseases by Adalat R (Nifedipine). Stuttgart-New York: Schattauer, 1986;270?314.
- Jee LD, Opie LH. Nifedipine for hypertension and angina pectoris: Interactions during combination therapy. In: Opie LH, ed. Calcium Antagonists and Cardiovascular Disease. New York: Raven Press, 1984;339?346.
- Bardet J, Baudet M, Rigaud M, et al. Diltiazem, a new calcium antagonist, versus propranolol in treatment of spontaneous angina pectoris (abstr). Am J Cardiol 1979; 43:416.
- Menasche S, Elkik F, Cocco G, et al. Synergistic antihypertensive effect of diltiazem combined with the alpha-adrenoceptor blocker alfuzosine (abstr). Ann NY Acad Sci (in press).
- Kleinbloesem CH, van Brummelen P, Sandberg THW, et al. Kinetic and haemodynamic interactions between nifedipine and propranolol in healthy subjects utilizing controlled rates of drug input. In: Kleinbloesem CH, ed. Nifedipine: Clinical Pharmacokinetics and Haemodynamic Effects. 's-Gravenhage: Drukkerij JH Pasmans BV, 1985;151?165.
- Kirch W. Dihydropyridine derivatives, influence on digoxin disposition and haemodynamics (abstr). Ann NY Acad Sci (in press).
- MacGregor GA: Hypertension. In: Krebs R, ed. Treatment of Cardiovascular Diseases by Adalat R (Nifedipine). Stuttgart: Schattauer, 1986; 231?258.
- Lahiri A, Dasgupta P, Rodrigues EA, et al. Acute drug withdrawal in patients with stable angina on long-term treatment with verapamil. In: Raftery EB, ed. Verapamil SR. Langhorne: ADIS Press International, 1987;18?29.
Cited by
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Cipriani, A., Saunders, K., Attenburrow, M.-J., Stefaniak, J., Panchal, P., Stockton, S., Lane, T. A., Tunbridge, E. M., Geddes, J. R., & Harrison, P. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.86 · Cited by 111
Ro 40–5967: A New Nondihydropyridine Calcium Antagonist
Clozel, J., Osterrieder, W., Kleinbloesem, C. H., Welker, H. A., Schläppi, B., Tudor, R., Hefti, F., Schmitt, R., & Eggers, H. (1991) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1991.tb00539.x · Cited by 103
Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension
Pedrinelli, R., Dell’Omo, G., & Mariani, M. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001201 · Cited by 72
Stroke precipitated by moderate blood pressure reduction
Fischberg, G. M., Lozano, E., Rajamani, K., Ameriso, S., & Fisher, M. (2000) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(00)00267-5 · Cited by 70
Metadata
- Authors
- Opie, L. H.
- Affiliations
- University of Cape Town (ZA)
- Corresponding author
- Opie, Lionel H.
- Venue
- Cardiovascular Drugs and Therapy
- Published
- 1988-07
- Volume
- 2
- Issue
- 2
- Pages
- 177-189
- ISSN
- 0920-3206 (ISSN-L)
- 1573-7241
- OpenAlex
- W1999013996
- Cited by
- 52
- References
- 99
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 5 · 2020: 2 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cardiovascular Drugs and Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- calcium channel blockers, verapamil, diltiazem, nifedipine, adverse drug reactions, contraindications, drug interactions, beta-blocker combination therapy, dihydropyridines, negative inotropic effect, myocardial failure, aortic stenosis, alpha-blockers, ACE inhibitors, diuretics, vasodilation
- MeSH terms
- Calcium Channel Blockers, Cardiovascular Diseases, Drug Interactions, Drug Therapy, Combination, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.